USD 83.51
(1.87%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 5.21 Billion USD | -1.44% |
2022 | 5.29 Billion USD | 14.67% |
2021 | 4.61 Billion USD | 7.03% |
2020 | 4.31 Billion USD | 1.99% |
2019 | 4.22 Billion USD | 12.68% |
2018 | 3.75 Billion USD | 4.86% |
2017 | 3.57 Billion USD | 7.22% |
2016 | 3.33 Billion USD | -3.89% |
2015 | 3.47 Billion USD | 0.29% |
2014 | 3.46 Billion USD | 100.75% |
2013 | 1.72 Billion USD | 0.76% |
2012 | 1.71 Billion USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 5.41 Billion USD | 3.78% |
2023 Q4 | 5.21 Billion USD | -8.89% |
2023 FY | 5.21 Billion USD | -1.44% |
2023 Q1 | 5.66 Billion USD | 7.08% |
2023 Q3 | 5.72 Billion USD | -0.5% |
2023 Q2 | 5.75 Billion USD | 1.53% |
2022 Q3 | 5.37 Billion USD | 6.33% |
2022 Q1 | 4.8 Billion USD | 4.18% |
2022 FY | 5.29 Billion USD | 14.67% |
2022 Q4 | 5.29 Billion USD | -1.53% |
2022 Q2 | 5.05 Billion USD | 5.12% |
2021 Q1 | 4.28 Billion USD | -0.58% |
2021 Q3 | 4.51 Billion USD | 3.79% |
2021 Q4 | 4.61 Billion USD | 2.26% |
2021 Q2 | 4.34 Billion USD | 1.42% |
2021 FY | 4.61 Billion USD | 7.03% |
2020 Q1 | 4.55 Billion USD | 7.61% |
2020 FY | 4.31 Billion USD | 1.99% |
2020 Q2 | 4.48 Billion USD | -1.47% |
2020 Q3 | 4.5 Billion USD | 0.54% |
2020 Q4 | 4.31 Billion USD | -4.33% |
2019 FY | 4.22 Billion USD | 12.68% |
2019 Q3 | 4.12 Billion USD | 1.98% |
2019 Q2 | 4.04 Billion USD | 2.8% |
2019 Q1 | 3.93 Billion USD | 4.77% |
2019 Q4 | 4.22 Billion USD | 2.6% |
2018 Q3 | 3.86 Billion USD | 2.74% |
2018 Q2 | 3.76 Billion USD | 2.23% |
2018 Q1 | 3.68 Billion USD | 2.85% |
2018 FY | 3.75 Billion USD | 4.86% |
2018 Q4 | 3.75 Billion USD | -2.92% |
2017 Q1 | 3.53 Billion USD | 5.99% |
2017 Q3 | 3.75 Billion USD | 3.11% |
2017 Q4 | 3.57 Billion USD | -4.59% |
2017 FY | 3.57 Billion USD | 7.22% |
2017 Q2 | 3.63 Billion USD | 2.83% |
2016 Q3 | 3.72 Billion USD | 0.08% |
2016 FY | 3.33 Billion USD | -3.89% |
2016 Q2 | 3.71 Billion USD | 3.83% |
2016 Q4 | 3.33 Billion USD | -10.27% |
2016 Q1 | 3.58 Billion USD | 3.08% |
2015 FY | 3.47 Billion USD | 0.29% |
2015 Q4 | 3.47 Billion USD | -1.78% |
2015 Q3 | 3.53 Billion USD | 0.57% |
2015 Q2 | 3.51 Billion USD | 3.29% |
2015 Q1 | 3.4 Billion USD | -1.7% |
2014 FY | 3.46 Billion USD | 100.75% |
2014 Q3 | 1.87 Billion USD | 0.11% |
2014 Q2 | 1.87 Billion USD | 2.02% |
2014 Q1 | 1.83 Billion USD | 6.43% |
2014 Q4 | 3.46 Billion USD | 84.69% |
2013 Q1 | 1.77 Billion USD | 3.86% |
2013 Q3 | 1.78 Billion USD | -2.36% |
2013 FY | 1.72 Billion USD | 0.76% |
2013 Q4 | 1.72 Billion USD | -3.2% |
2013 Q2 | 1.82 Billion USD | 2.64% |
2012 Q3 | 1.88 Billion USD | 0.0% |
2012 FY | 1.71 Billion USD | 0.0% |
2012 Q4 | 1.71 Billion USD | -9.37% |
Name | Inventory | Inventory Difference |
---|---|---|
Phreesia, Inc. | - USD | -Infinity% |
Accuray Incorporated | 138.32 Million USD | -3671.58% |
Align Technology, Inc. | 296.9 Million USD | -1657.145% |
Elevance Health Inc. | -46.33 Billion USD | 111.26% |
AxoGen, Inc. | 23.02 Million USD | -22562.902% |
Boston Scientific Corporation | 2.48 Billion USD | -110.024% |
CVS Health Corporation | 18.02 Billion USD | 71.057% |
Cardinal Health, Inc. | 14.95 Billion USD | 65.12% |
Centene Corporation | - USD | -Infinity% |
DaVita Inc. | 143.1 Million USD | -3545.575% |
HCA Healthcare, Inc. | 2.02 Billion USD | -158.14% |
Hologic, Inc. | 679.8 Million USD | -667.432% |
Humana Inc. | - USD | -Infinity% |
IDEXX Laboratories, Inc. | 380.28 Million USD | -1271.877% |
Laboratory Corporation of America Holdings | 474.6 Million USD | -999.241% |
Masimo Corporation | 545 Million USD | -857.248% |
McKesson Corporation | 21.13 Billion USD | 75.32% |
Patterson Companies, Inc. | 782.89 Million USD | -566.37% |
Quest Diagnostics Incorporated | 190 Million USD | -2645.789% |
ResMed Inc. | 822.25 Million USD | -534.479% |
Henry Schein, Inc. | 1.81 Billion USD | -187.438% |
Teladoc Health, Inc. | 29.51 Million USD | -17576.956% |
Universal Health Services, Inc. | 216.98 Million USD | -2304.28% |
Veeva Systems Inc. | - USD | -Infinity% |
Baxter International Inc. | 2.82 Billion USD | -84.738% |
Becton, Dickinson and Company | 3.27 Billion USD | -59.395% |
Intuitive Surgical, Inc. | 1.22 Billion USD | -327.413% |
Danaher Corporation | 2.59 Billion USD | -101.118% |
Stryker Corporation | 4.84 Billion USD | -7.722% |